The incremental impact of residual SYNTAX score on long-term clinical outcomes in patients with multivessel coronary artery disease treated by percutaneous coronary interventions

Catheterization and Cardiovascular Interventions

Volumn 86, Issue 1, 2015, Pages 3-10

  Witberg, Guy ^a   Lavi, Ifat ^a   Assali, Abid ^a   Vaknin Assa, Hana ^a   Lev, Eli ^a   Kornowski, Ran ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

coronary artery bypass graft; multivessel revascularization; percutaneous coronary interventions; residual SYNTAX score

Indexed keywords

ACUTE CORONARY SYNDROME; ADVERSE OUTCOME; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCOMPLETE CORONARY REVASCULARIZATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REPEAT PROCEDURE; RESIDUAL SYNTAX SCORE; RETREATMENT; RETROSPECTIVE STUDY; SYNTAX SCORE; CORONARY ANGIOGRAPHY; EPIDEMIOLOGY; INCIDENCE; ISRAEL; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; TIME FACTOR; TREATMENT OUTCOME;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ISRAEL; MALE; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; ROC CURVE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84931955951     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25753     Document Type: Article

References (21)

1. McLellan CS, Ghali WA, Labinaz M, Davis RB, Galbraith PD, Southern DA, Shrive FM, Knudtson ML,; Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) Investigators. Association between completeness of percutaneouscoronary revascularization and post-procedure outcomes. Am Heart J 2005; 150: 800-806.
2. Bourassa MG, Yeh W, Holubkov R, Sopko G, Detre KM,; for theinvestigators of the NHLBI PTCA Registry. Long-term outcome of patients with incomplete vscomplete revascularization after multivesselPTCA.A report from the NHLBI PTCA Registry. Eur Heart J 1998; 19: 103-111.
3. Rosner GF, Kirtane AJ, Genereux P, Lansky AJ, Cristea E, Gersh BJ, Weisz G, Parise H, Fahy M, Mehran R, Stone GW,. Impact of the presence and extent of incomplete angiographic revascularization after percutaneous coronary intervention in acute coronary syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. Circulation 2012; 125: 2613-2620.
4. Hannan EL, Wu C, Walford G, Holmes DR, Jones RH, Sharma S, King SB III,. Incomplete revascularization in the era of drug-eluting stents: Impact on adverse outcomes. J Am Coll Cardiol Cardiovasc Interv 2009; 2: 17-25.
5. Bourassa MG, Holubkov R, Yeh W, Detre KM,. Strategy of complete revascularization in patients with multivessel coronary artery disease (a report from the 1985-1986 NHLBI PTCA Registry). Am J Cardiol 1992; 70: 174-178.
6. Cowley MJ, Vandermael M, Topol EJ, Whitlow PL, Dean LS, Bulle TM, Ellis SG,. for the Multivessel Angioplasty Prognosis Study (MAPS) Group. Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty? J Am Coll Cardiol 1993; 22: 1289-1297.
7. Garcia S, Sandoval Y, Roukoz H, Adabag S, Canoniero M, Yannopoulos D, Brilakis ES,. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. J Am Coll Cardiol 2013; 62: 1421-1431.
8. Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA,. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update:a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2012; 59: 857-881.
9. De Bruyne B,. Multivessel disease: from reasonably incomplete to functionally complete revascularization. Circulation 2012; 125: 2557-2559.
10. Dauerman HL,. Reasonable incomplete revascularization. Circulation 2011; 123: 2337-2340.
11. Taggart DP,. Incomplete revascularization: appropriate and inappropriate. Eur J Cardiothorac Surg 2012; 41: 542-543.
12. Gussl M, Faxon DP, Bell MR, Holmes DR, Gersh BJ,. Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease. Circ Cardiovasc Interv 2012; 5: 597-604.
13. Généreux P, Palmerini T, Caixeta A, Rosner G, Green P, Dressler O, Xu K, Parise H, Mehran R, Serruys PW, Stone GW,. Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: The residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. J Am Coll Cardiol 2012; 59: 2165-2174.
14. Malkin CJ, George V, Ghobrial MS, Krishnan A, Siotia A, Raina T, Morton AC, Gunn J,. Residual SYNTAX score after PCI for triple vessel coronary artery disease: Quantifying the adverse effect of incomplete revascularisation. EuroIntervention 2013; 8: 1286-1295.
15. Capodanno D, Chisari A, Giacoppo D, Bonura S, Lavanco V, Capranzano P, Caggegi A, Ministeri M, Tamburino C,. Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention. Catheter Cardiovasc Interv 2013; 82: 333-340.
16. Malkin CJ, Ghobrial MS, Raina T, Siotia A, Morton AC, Gunn J,. Impact of incomplete revascularization in patients undergoing PCI for unprotected left main stem stenosis. Catheter Cardiovasc Interv 2013; 81: 939-946.
17. Farooq V, Serruys PW, Bourantas CV, Zhang Y, Muramatsu T, Feldman T, Holmes DR, Mack M, Morice MC, Ståhle E, Colombo A, de Vries T, Morel MA, Dawkins KD, Kappetein AP, Mohr FW,. Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score. Circulation 2013; 128: 141-151.
18. Farooq V, Serruys PW, Garcia-Garcia HM, Zhang Y, Bourantas CV, Holmes DR, Mack M, Feldman T, Morice MC, Ståhle E, James S, Colombo A, Diletti R, Papafaklis MI, de Vries T, Morel MA, van Es GA, Mohr FW, Dawkins KD, Kappetein AP, Sianos G, Boersma E,. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. J Am Coll Cardiol 2013; 61: 282-294.
19. Bental T, Assali A, Vaknin-Assa H, Lev EI, Brosh D, Fuchs S, Battler A, Kornowski R,. A comparative analysis of major clinical outcomes using drug-eluting stents versus bare-metal stents in a large consecutive patient cohort. Catheter Cardiovasc Interv 2010; 76: 374-380.
20. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Katus HA, Lindahl B, Morrow DA, et al., Third universal definition of myocardial infarction. Circulation 2012; 126: 2020-2035.
21. Assali A, Vaduganathan M, Vaknin-Assa H, Lev EI, Brosh D, Teplitsky I, Bental T, Battler A, Kornowski R,. Comparison of late (3-year) registry data outcomes using bare metal versus drug-eluting stents for treating ST-segment elevation acute myocardial infarctions. Am J Cardiol 2012; 109: 1563-1568.